This event took place on October 5, 2021. To view a replay of the webinar on demand, click here

In this webinar, we discuss what we know about FDA regulation of cannabis and cannabis-derived products and look at trends in recent FDA enforcement over CBD products. 

Topics include:

  • Pathways for FDA authorization of cannabis and other cannabis-derived products, including CBD
  • New Drugs
  • New Dietary Ingredient Notification – Foods/Dietary Supplements
  • New Animal Foods/Drugs
  • What other cannabinoids are of commercial interest
  • Other legal concerns around marketing cannabinoids


Click here to view more webinars on demand in our Seed to Sale Series.

CLE points
1.00 General credit hour pending in CA/DE/GA/NC/SC/TX/VA